USFDA completes inspection at Solara Active Pharma’s Chennai facility

15 Dec 2018 Evaluate

Solara Active Pharma Science has successfully completed the US Food and Drug Administration’s (USFDA) inspection at Solara Research Centre (SRC), Chennai with zero 483s inspectional observations.

The centre is equipped with high-end infrastructure with advanced analytical capabilities, strong IP assessment skills and global regulatory expertise. SRC is also an important pivot in Solara's Contract Research and manufacturing services (CRAMS) vertical.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

551.50 1.15 (0.21%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×